INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 170 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $95,511,497 | +447.9% | 1,394,532 | +453.6% | 0.55% | +410.3% |
| Q1 2024 | $17,432,864 | +104.9% | 251,920 | +112.1% | 0.11% | +91.1% |
| Q4 2023 | $8,507,238 | +24.0% | 118,783 | -9.8% | 0.06% | +19.1% |
| Q3 2023 | $6,860,253 | +185.1% | 131,700 | +246.6% | 0.05% | +161.1% |
| Q2 2023 | $2,406,160 | -11.1% | 38,000 | -24.0% | 0.02% | -25.0% |
| Q1 2023 | $2,707,500 | -61.0% | 50,000 | -77.1% | 0.02% | -75.5% |
| Q4 2020 | $6,947,000 | -51.3% | 218,473 | -60.7% | 0.10% | -54.8% |
| Q3 2020 | $14,275,000 | +107.2% | 556,312 | +107.3% | 0.22% | +108.7% |
| Q2 2020 | $6,890,000 | -6.1% | 268,400 | -43.8% | 0.10% | -28.8% |
| Q1 2020 | $7,338,000 | -15.3% | 477,426 | -13.0% | 0.15% | +124.6% |
| Q3 2017 | $8,663,000 | +332.7% | 548,955 | +997.9% | 0.06% | +182.6% |
| Q3 2015 | $2,002,000 | +150.2% | 50,000 | +99.8% | 0.02% | +360.0% |
| Q2 2015 | $800,000 | +77.0% | 25,030 | +32.4% | 0.01% | -16.7% |
| Q1 2015 | $452,000 | -55.7% | 18,908 | -67.3% | 0.01% | -64.7% |
| Q4 2014 | $1,021,000 | +24.1% | 57,853 | -3.6% | 0.02% | 0.0% |
| Q3 2014 | $823,000 | -61.1% | 59,995 | -52.2% | 0.02% | -63.8% |
| Q2 2014 | $2,116,000 | -40.2% | 125,493 | -35.5% | 0.05% | -51.5% |
| Q1 2014 | $3,537,000 | – | 194,563 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 375,000 | $15,308,000 | 5.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 113,258 | $4,623,000 | 2.06% |
| Tri Locum Partners LP | 150,783 | $6,155,000 | 2.02% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $2,495,000 | 1.64% |
| Vantage Consulting Group Inc | 226,670 | $9,252,000 | 1.61% |
| Nicholas Investment Partners, LP | 598,261 | $24,421,000 | 1.53% |
| Bellevue Group AG | 3,609,919 | $147,357,000 | 1.44% |
| GENERAL AMERICAN INVESTORS CO INC | 350,804 | $14,320,000 | 1.20% |
| Rhenman & Partners Asset Management AB | 429,728 | $17,541,000 | 1.19% |
| WASATCH ADVISORS LP | 6,506,789 | $265,607,000 | 1.08% |